Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000698730 | SCV000827411 | likely benign | Primary ciliary dyskinesia | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000698730 | SCV002728192 | benign | Primary ciliary dyskinesia | 2023-12-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV003144544 | SCV003831734 | uncertain significance | Primary ciliary dyskinesia 3 | 2020-08-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000698730 | SCV002081787 | uncertain significance | Primary ciliary dyskinesia | 2019-10-28 | no assertion criteria provided | clinical testing |